ID Management A/S’s AMAG Pharmaceuticals AMAG Stock Holding History

ID Management A/S’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,816	Closed	-$112K	–	330
2015 Q3	$112K	Buy	+2,816	New	+$175K	0.05%	220
2015 Q1	$55K	Buy	+1,000	New	+$47.7K	0.03%	263

Other funds holding AMAG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

ID Management A/S's AMAG Position: Q4 2015 in Review

ID Management A/S sold out of AMAG Pharmaceuticals (AMAG) in Q4 2015, closing a stake of 2,816 shares — an estimated $112K sold.

ID Management A/S first reported a position in AMAG in Q1 2015 and held it in 2 quarters. The position peaked at $112K in Q3 2015. 172 funds tracked by Wall St. Rank hold AMAG as of Q4 2015.

ID Management A/S reported no remaining AMAG Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
ID Management A/S sold 2,816 AMAG Pharmaceuticals shares in Q4 2015, an estimated $112K.
ID Management A/S first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 2 quarters.
ID Management A/S's AMAG Pharmaceuticals position peaked at $112K in Q3 2015.
172 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2015.

Based on ID Management A/S's 13F filing for Q4 2015, filed 13 Jan 2016.